This post was originally published on this siteThe White House is announcing a Covid-19 vaccine rollout plan Thursday for children under 5, partnering with state and local governments, health care providers, federal pharmacy partners, national and community-based organizations and other entities to ship and distribute vaccines across the country following...
This post was originally published on this siteTests by Pfizer-BioNTech show three COVID shots for children under 5 appear to be safe and effective. The dose is one-tenth as much as for adults.
This post was originally published on this siteOutside experts are exploring the need to reconfigure vaccines in order to better protect the nation against new variants.
Senate Majority Leader Chuck Schumer (D-N.Y.) and Sen. Mitt Romney (R-Utah) on Monday announced a $10 billion deal to fund COVID-19 treatments, vaccines, and related domestic tools to fight the pandemic. But the deal, lower than the $22.5 billion requested by the White House, doesn’t contain funds for helping other countries fight the pandemic, slightly complicating the deal’s passage through the Democratic-controlled House.
Romney, the top GOP negotiator, said the package would address America’s “urgent COVID needs” and highlighted that it “will not cost the American people a single additional dollar,” since the funds were repurposed from previous COVID-19 relief packages. Schumer, the lead Democratic bargainer, said that “while we were unable to reach an agreement on international aid in this new agreement, many Democrats and Republicans are committed to pursuing a second supplemental later this spring.”
The White House, which had warned the federal government was running out of funds for vaccines and treatments, backed the compromise deal. “Every dollar we requested is essential,” said Press Secretary Jen Psaki. “But time is of the essence. We urge Congress to move promptly on this $10 billion package because it can begin to fund the most immediate needs.”
Republican negotiators over the weekend couldn’t agree on a unified position on the international aid, with some insisting it be tied to President Biden dropping his plan to halt pandemic border rules, Politico reports. Democratic negotiators agreed to drop the funding to get the domestic funds on the move, but they called it penny-wise, pound-foolish.
Sen. Chris Coons (D-Del.) said it was a “grave mistake” and “fiscally foolish” to not send tens of millions of unused U.S. vaccines aboard. “We know that the virus is going to mutate much more effectively in large bodies of unvaccinated people,” said Rep. Jake Auchincloss (D-Mass.), co-chair of the Global Vaccination Caucus, and mutations travel around the world.
White House officials say U.S. has exhausted funds to buy potential fourth vaccine dose for all Americans
This post was originally published on this siteAs a congressional stalemate stretches into its third week, officials warn it will hurt pandemic readiness.
This post was originally published on this siteModerna requested emergency use authorization from the Food and Drug Administration for a fourth dose of its COVID-19 vaccine for people 18 and over.
This post was originally published on this siteModerna is going head-to-head with Pfizer-BioNTech for the opportunity to vaccinate the youngest children, the only Americans still not eligible for shots.
This post was originally published on this siteThe Biden administration has made a marked shift toward a new phase where COVID-19 is no longer treated as a crisis, rolling out a series of new programs aimed at increasing access to treatment and boosting vaccine capacity for the future.The change…
This post was originally published on this siteThe Centers for Disease Control and Prevention (CDC) on Tuesday issued new COVID-19 mRNA vaccine guidance, expanding the recommended time between the initial two vaccine doses to eight weeks for some people over the age of 12,…
This post was originally published on this site Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation. Pfizer, whose vaccinee developed with German company...